1-6 of 6
Dae Seog Heo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Spectrum: Phase II Study of Tislelizumab Plus Pemetrexed in Patients with Relapsed or Refractory (R/R) Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): The Korean Cancer Study Group LY22-07

Tae Min Kim, Jung Sun Kim, Gyeong-Won Lee, Myung-Won Lee, Jeonghwan Youk, Hyun Jung Lee, Sung-Nam Lim, Soyeon Kim, Yoon Kyung Jeon, Chul-Kee Park, Dae Seog Heo
Journal: Blood
Blood (2024) 144 (Supplement 1): 3102.
https://doi.org/10.1182/blood-2024-202877
Published: 2024
Journal Articles

Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: An Open-Label, Single-Arm, Multicenter Phase 2 Study

Won-Seog Kim, Hyeon-Seok Eom, Su-Peng Yeh, MD, Seok-Goo Cho, MD PhD, Dae Seog Heo, MD, Jin Seok Kim, MD PhD, Ming Yao, MD, Jun Zhu, Grace Gao, Lijia Zhang, Ming Qi, MD PhD, Huiqiang Huang, Yok Lam Kwong, MD FRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 1617.
https://doi.org/10.1182/blood-2018-99-111885
Published: 2018
Journal Articles

Brentuximab Vedotin Plus Doxorubicin, Vinblastine, Dacarbazine (A+AVD) As Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients with Previously Untreated Stage III or IV Hodgkin Lymphoma (HL): The Phase 3 Echelon-1 Study

Joseph M Connors, MD, Wojciech Jurczak, PhDMD, David J. Straus, MD, Stephen M Ansell, MD PhD, Won Seog Kim, MD, Ph. D., Andrea Gallamini, MD, Anas Younes, MD, Sergei Alekseev, PhD, Arpad Illes, MD, Marco Picardi, Ewa Lech-Maranda, MDPhD, Yasuhiro Oki, MD, Tatyana A Feldman, MD, Piotr Smolewski, MD PhD, Kerry J Savage, BSc, MD MSc, Nancy L. Bartlett, MD, Jan Walewski, MD PhD, Robert W. Chen, MD, Rod Ramchandren, MD, Pier Luigi Zinzani, MD, David Cunningham, MD FRCP, Dae Seog Heo, MD, Andras Rosta, MD, Neil Josephson, MD, Katherine L. Ruffner, MD, Jessica Sachs, Rachael Liu, PhD, Hina Jolin, Pharm D, Dirk Huebner, MD, John A. Radford, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 6.
https://doi.org/10.1182/blood.V130.Suppl_1.6.6
Published: 2017
Journal Articles

Diagnosis of Secondary Peripheral Neurolymphomatosis: A Multi-Center Experience

Ja Min Byun, Jeong-Ok Lee, Tae Min Kim, MD PhD, Bhumsuk Keam, Dae Seog Heo, Ki Hwan Kim, Soo-Mee Bang, Jong Seok Lee
Journal: Blood
Blood (2016) 128 (22): 4222.
https://doi.org/10.1182/blood.V128.22.4222.4222
Published: 2016
Journal Articles

Ifosfamide, Methotrexate, Etoposide, and Prednisolone (IMEP) Plus L-Asparaginase As a First-Line Therapy Improves Outcomes In Stage III/IV NK/T-Cell Lymphoma, Nasal Type (NTCL)

Miso Kim, MD, Ki Hwan Kim, MD, Bhumsuk Keam, MD, Se-Hoon Lee, MD, PhD, Dong-Wan Kim, MD, PhD, Jong Seok Lee, MD, PhD, Dae Seog Heo, MD, PhD, Tae Min Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4347.
https://doi.org/10.1182/blood.V122.21.4347.4347
Published: 2013
Journal Articles

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I E /II E extranodal NK/T-cell lymphoma, nasal type

Clinical Trials & Observations
Tae Min Kim, Yeon Hee Park, Sang-Yoon Lee, Ji-Hoon Kim, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Chul Woo Kim, Dae Seog Heo, Yung-Jue Bang, Kee-Hyun Chang, Noe Kyeong Kim
Journal: Blood
Blood (2005) 106 (12): 3785–3790.
https://doi.org/10.1182/blood-2005-05-2056
Published: 2005